The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
Open accessAbstract
Background Approximately 85% of nasal polyps (NPs) in white subjects are characterized by prominent eosinophilia. IL-5 is the key driver of eosinophilic differentiation and survival. Objective We sought to investigate the therapeutic potential of inhibiting IL-5 with a humanized mAb as treatment for severe nasal polyposis. Methods Thirty patients with severe nasal polyposis (grade 3 or 4 or recurrent after surgery) refractory to corticosteroid therapy were randomized in a double-blind fashion to receive either 2 single intravenous injections (28 days apart) of 750 mg of mepolizumab (n = 20) or placebo (n = 10). Change from baseline in NP score was assessed monthly until 1 month after the last dose (week 8). Computed tomographic scans were also performed at week 8. Results Twelve of 20 patients receiving mepolizumab had a significantly improved NP score and computed tomographic scan score compared with 1 of 10 patients receiving placebo at week 8 versus baseline. Conclusion Mepolizumab achieved a statistically significant reduction in NP size for at least 1 month after dosing in 12 of 20 patients. IL-5 inhibition is a potential novel therapeutic approach in patients with severe eosinophilic nasal polyposis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These biological treatments have a potentially major effect on NO and the size of NP.”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [182]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
Fokkens, W. J., Lund, V. J., Hopkins, C., Hellings, P. W., Kern, R., Reitsma, S., Toppila-Salmi, S., Bernal-Sprekelsen, M., Mullol, J., Alobid, I., et al. (2020) · Rhinology journal · doi:10.4193/rhin20.600 · Cited by 5,882
Self-citationA Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80702-3 · Cited by 3,589
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W. R., Sousa, A. R., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,873
Self-citationInterleukin-5, eosinophils, and disease
Sanderson, C. (1992) · Blood · doi:10.1182/blood.v79.12.3101.3101 · Cited by 860
Differentiation of chronic sinus diseases by measurement of inflammatory mediators
Zele, T. V., Claeys, S., Gevaert, P., Maele, G. V., Holtappels, G., Cauwenberge, P. V., & Bachert, C. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01225.x · Cited by 775
Self-citationA Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma
Flood-Page, P. T., Swenson, C. A., Faiferman, I., Matthews, J. G., Williams, M. J. A., Brannick, L., Robinson, D. S., Wenzel, S. E., Busse, W. W., Hansel, T. T., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-085oc · Cited by 750
Total and specific IgE in nasal polyps is related to local eosinophilic inflammation
Bachert, C., Gevaert, P., Holtappels, G., Johansson, S. G. O., & Cauwenberge, P. V. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112374 · Cited by 702
Self-citationDifferent types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease
Zhang, N., Zele, T. V., Perez-Novo, C. A., Bruaene, N. V., Holtappels, G., Ruyck, N. D., Cauwenberge, P. V., & Bachert, C. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.07.008 · Cited by 621
Self-citationCao, P., Li, H., Wang, B.-F., Wang, S.-B., You, X., Cui, Y., Wang, D. Y., Desrosiers, M. Y., & Liu, Z. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.017 · Cited by 617
Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab
Rothenberg, M. E., Klion, A. D., Roufosse, F. E., Kahn, J., Weller, P. F., Simon, H., Schwartz, L. B., Rosenwasser, L. J., Ring, J., Griffin, E. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070812 · Cited by 590
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers
Tomassen, P., Vandeplas, G., Zele, T. V., Cardell, L., Arebro, J., Olze, H., Förster‐Ruhrmann, U., Kowalski, M. L., Olszewska-Ziąber, A., Holtappels, G., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.12.1324 · Cited by 1,168
Self-citationInternational consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B. S., DeConde, A. S., Luong, A., Poetker, D. M., Soler, Z. M., Welch, K. C., Wise, S. K., et al. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 1,084
Self-citationInternational Consensus Statement on Allergy and Rhinology: Rhinosinusitis
Orlandi, R. R., Kingdom, T. T., Hwang, P. H., Smith, T. L., Alt, J. A., Baroody, F. M., Batra, P. S., Bernal‐Sprekelsen, M., Bhattacharyya, N., Chandra, R. K., et al. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21695 · Cited by 892
Targeting key proximal drivers of type 2 inflammation in disease
Gandhi, N. A., Bennett, B. L., Graham, N. M. H., Pirozzi, G., Stahl, N., & Yancopoulos, G. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd4624 · Cited by 766
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
Gevaert, P., Omachi, T. A., Corren, J., Mullol, J., Han, J. K., Lee, S. E., Kaufman, D., Ligueros‐Saylan, M., Howard, M., Zhu, R., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.032 · Cited by 740
Self-citationBachert, C., Mannent, L., Naclerio, R. M., Mullol, J., Ferguson, B. J., Gevaert, P., Hellings, P., Jiao, L., Wang, L., Evans, R. R., et al. (2016) · JAMA · doi:10.1001/jama.2015.19330 · Cited by 794
Self-citationOmalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Gevaert, P., Calus, L., Van Zele, T., Blomme, K., De Ruyck, N., Bauters, W., Hellings, P., Brusselle, G., De Bacquer, D., van Cauwenberge, P., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.047 · Cited by 744
Self-citationHan, J. K., Bachert, C., Fokkens, W. J., Desrosiers, M. Y., Wagenmann, M., Lee, S. E., Smith, S. G., Martin, N., Mayer, B., Yancey, S. W., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00097-7 · Cited by 631
Self-citationChronic Rhinosinusitis with Nasal Polyps
Stevens, W. W., Schleimer, R. P., & Kern, R. C. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.04.012 · Cited by 584
Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis
Schleimer, R. P. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100401 · Cited by 548
Executive Summary of EPOS 2020 Including Integrated Care Pathways
Fokkens, W. J., Lund, V. J., Hopkins, C. L., Hellings, P. W., Kern, R. C., Reitsma, S., Toppila-Salmi, S. K., Bernal‐Sprekelsen, M. S., & Mullol, J. (2020) · Rhinology Journal · doi:10.4193/rhin20.601 · Cited by 548
Akdis, C. A., Bachert, C., Cingi, C., Dykewicz, M. S., Hellings, P. W., Naclerio, R. M., Schleimer, R. P., & Ledford, D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.02.036 · Cited by 538
Self-citationReduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Bachert, C., Sousa, A. R., Lund, V. J., Scadding, G. K., Gevaert, P., Nasser, S. M., Durham, S. R., Cornet, M., Kariyawasam, H. H., Gilbert, J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.044 · Cited by 503
Self-citationCommonality of the IL-4/IL-13 pathway in atopic diseases
Gandhi, N. A., Pirozzi, G., & Graham, N. M. H. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1298443 · Cited by 493
Targeting eosinophils in allergy, inflammation and beyond
Fulkerson, P. C., & Rothenberg, M. E. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3838 · Cited by 481
Bal, S. M., Bernink, J. H., Nagasawa, M., Groot, J., Shikhagaie, M., Golebski, K., van Drunen, C. M., Lutter, R., Jonkers, R. E., Hombrink, P., et al. (2016) · Nature Immunology · doi:10.1038/ni.3444 · Cited by 473
Diagnosis and management of NSAID ‐Exacerbated Respiratory Disease (N‐ ERD )—a EAACI position paper
Kowalski, M. L., Agache, I. O., Bavbek, S., Bakırtaş, A., Blanca, M., Bochenek, G., Bonini, M., Heffler, E. M., Klimek, L., Laidlaw, T. M., et al. (2018) · Allergy · doi:10.1111/all.13599 · Cited by 360
Fajt, M. L., & Wenzel, S. E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1871 · Cited by 359
Bachert, C., Marple, B. F., Schlosser, R. J., Hopkins, C. L., Schleimer, R. P., Lambrecht, B. N., Bröker, B. M., Laidlaw, T. M., & Song, W. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00218-1 · Cited by 352
Self-citationCurrent and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis
Bachert, C., Zhang, L., & Gevaert, P. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.010 · Cited by 315
Self-citationTherapies for allergic inflammation: refining strategies to induce tolerance
Akdiş, C. A. (2012) · Nature Medicine · doi:10.1038/nm.2754 · Cited by 295
Immunopathology of chronic rhinosinusitis
Kato, A. (2015) · Allergology International · doi:10.1016/j.alit.2014.12.006 · Cited by 292
Adult-onset asthma: is it really different?
de Nijs, S. B., Venekamp, L. N., & Bel, E. H. (2013) · European Respiratory Review · doi:10.1183/09059180.00007112 · Cited by 297
Innate Lymphoid Cells in Mucosal Immunity
Panda, S. K., & Colonna, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00861 · Cited by 288
United airway disease: current perspectives
Junior, P. F. G.-B., Aun, M. V., Takejima, P., Kalil, J. E., & Agondi, R. C. (2016) · Journal of Asthma and Allergy · doi:10.2147/jaa.s81541 · Cited by 249
Contributions of Eosinophils to Human Health and Disease
Klion, A. D., Ackerman, S. J., & Bochner, B. S. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032756 · Cited by 246
Bachert, C., Pawankar, R., Zhang, L., Bunnag, C., Fokkens, W. J., Hamilos, D. L., Jirapongsananuruk, O., Kern, R. C., Meltzer, E. O., Mullol, J., et al. (2014) · World Allergy Organization Journal · doi:10.1186/1939-4551-7-25 · Cited by 247
Self-citationOykhman, P., Paramo, F. A., Bousquet, J. J., Kennedy, D. W., Brignardello‐Petersen, R., & Chu, D. K. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.09.009 · Cited by 253
Mjösberg, J., & Spits, H. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.009 · Cited by 223
Calus, L., Bruaene, N. V., Bosteels, C., Dejonckheere, S., Zele, T. V., Holtappels, G., Bachert, C., & Gevaert, P. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0269-4 · Cited by 214
Self-citationNagase, H., Ueki, S., & Fujieda, S. (2020) · Allergology International · doi:10.1016/j.alit.2020.02.002 · Cited by 211
Diagnosis and management of rhinosinusitis: a practice parameter update
Peters, A. T., Spector, S. L., Hsu, J., Hamilos, D. L., Baroody, F. M., Chandra, R. K., Grammer, L. C., Kennedy, D. W., Cohen, N. A., Kaliner, M., et al. (2014) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2014.07.025 · Cited by 210
Biologics for chronic rhinosinusitis with nasal polyps
Bachert, C., Zhang, N., Cavaliere, C., Weiping, W., Gevaert, E., & Krysko, O. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.020 · Cited by 209
Self-citationChronic Rhinosinusitis with Nasal Polyps
Hopkins, C. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmcp1800215 · Cited by 196
Agache, I. O., & Akdiş, C. A. (2016) · Allergology International · doi:10.1016/j.alit.2016.04.011 · Cited by 200
Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma
Roufosse, F. E. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00049 · Cited by 191
Position paper on olfactory dysfunction: 2023
Whitcroft, K. L., Altundağ, A., Balungwe, P. B., Boscolo‐Rizzo, P., Douglas, R. G., Enecilla, M. L. B., Fjældstad, A. W., Fornazieri, M. A., Frasnelli, J., Gane, S. B., et al. (2023) · Rhinology Journal · doi:10.4193/rhin22.483 · Cited by 219
Jonstam, K., Swanson, B. N., Mannent, L., Cardell, L., Tian, N., Wang, Y., Zhang, D., Fan, C., Holtappels, G., Hamilton, J. D., et al. (2018) · Allergy · doi:10.1111/all.13685 · Cited by 187
Self-citationEndotype-driven treatment in chronic upper airway diseases
Greve, G. D., Hellings, P. W., Fokkens, W. J., Pugin, B., Steelant, B., & Seys, S. (2017) · Clinical and Translational Allergy · doi:10.1186/s13601-017-0157-8 · Cited by 175
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes
Roufosse, F. E., Kahn, J., Gleich, G. J., Schwartz, L. B., Singh, A. D., Rosenwasser, L. J., Denburg, J. A., Ring, J., Rothenberg, M. E., Sheikh, J. K., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.055 · Cited by 176
Hellings, P. W., Fokkens, W. J., Bachert, C., Akdiş, C. A., Bieber, T. R. M., Agache, I. O., Bernal‐Sprekelsen, M. S., Canonica, G. W., Gevaert, P., Joos, G., et al. (2017) · Allergy · doi:10.1111/all.13162 · Cited by 178
Self-citationFormation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin
Takabayashi, T., & Schleimer, R. P. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.027 · Cited by 167
Chronic rhinosinusitis and asthma: novel understanding of the role of IgE ‘above atopy’
Bachert, C., & Zhang, N. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02559.x · Cited by 156
Self-citationType 2 chronic inflammatory diseases: targets, therapies and unmet needs
Kolkhir, P., Akdiş, C. A., Akdiş, M., Bachert, C., Bieber, T. R. M., Canonica, G. W., Guttman‐Yassky, E., Metz, M., Mullol, J., Palomares, Ó., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00750-1 · Cited by 180
Self-citationGevaert, P., Han, J. K., Smith, S. G., Sousa, A. R., Howarth, P. H., Yancey, S. W., Chan, R. H., & Bachert, C. (2022) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22994 · Cited by 153
Self-citationEndoscopic Sinus Surgery for Type‐2 CRS wNP: An Endotype‐Based Retrospective Study
Alsharif, S., Jonstam, K., Zele, T. V., Gevaert, P., Holtappels, G., & Bachert, C. (2019) · The Laryngoscope · doi:10.1002/lary.27815 · Cited by 150
Self-citationEmerging molecular phenotypes of asthma
Ray, A., Oriss, T. B., & Wenzel, S. E. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00070.2014 · Cited by 147
Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma
Peters, M. C., & Wenzel, S. E. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33005-3 · Cited by 147
Medical Therapies for Adult Chronic Sinusitis: A Systematic Review
Rudmik, L., & Soler, Z. M. (2015) · JAMA · doi:10.1001/jama.2015.7544 · Cited by 166
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes
Wenzel, S. E. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3631ci · Cited by 152
Barrier function of the nasal mucosa in health and type‐2 biased airway diseases
Zhang, N., Crombruggen, K. V., Gevaert, E., & Bachert, C. (2015) · Allergy · doi:10.1111/all.12809 · Cited by 146
Self-citationMixed T Helper Cell Signatures In Chronic Rhinosinusitis with and without Polyps
Derycke, L., Eyerich, S., Crombruggen, K. V., Perez-Novo, C. A., Holtappels, G., Ruyck, N. D., Gevaert, P., & Bachert, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097581 · Cited by 141
Self-citationChen, S., Zhou, A., Emmanuel, B., Thomas, K. S., & Guiang, H. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1815682 · Cited by 137
Agache, I. O., Song, Y., Alonso‐Coello, P., Vogel, Y., Rocha, C., Solà, I., Santero, M., Akdiş, C. A., Akdiş, M., Canonica, G. W., et al. (2021) · Allergy · doi:10.1111/all.14809 · Cited by 138
Self-citationJacobsen, E. A., Jackson, D. J., Heffler, E. M., Mathur, S. K., Bredenoord, A. J., Pavord, I. D., Akuthota, P., Roufosse, F. E., & Rothenberg, M. E. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-125918 · Cited by 136
Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes
Cao, P.-P., Wang, Z.-C., Schleimer, R. P., & Liu, Z. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.10.014 · Cited by 135
Nasal polyps in patients with asthma: prevalence, impact, and management challenges
Mullol, J., & Langdon, C. (2016) · Journal of Asthma and Allergy · doi:10.2147/jaa.s86251 · Cited by 130
International consensus statement on allergy and rhinology: Olfaction
Patel, Z. M., Holbrook, E. H., Turner, J. H., Adappa, N. D., Albers, M. W., Altundağ, A., Appenzeller, S., Costanzo, R. M., Croy, I., Davis, G. E., et al. (2022) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22929 · Cited by 142
Rethinking neutrophils and eosinophils in chronic rhinosinusitis
Delemarre, T., Bochner, B. S., Simon, H., & Bachert, C. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.03.024 · Cited by 128
Self-citationA loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis
Kristjansson, R. P., Benónísdóttir, S., Davidsson, O. B., Oddsson, Á., Tragante, V., Sigurdsson, J. K., Stefánsdóttir, L., Jonsson, S., Jensson, B. Ö., Arthur, J. G., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0314-6 · Cited by 128
Relationships among Allergic Rhinitis, Asthma, and Chronic Rhinosinusitis
Rosati, M. G., & Peters, A. T. (2016) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2016.30.4252 · Cited by 122
Eosinophils and tissue remodeling: Relevance to airway disease
Siddiqui, S., Bachert, C., Bjermer, L. H., Buchheit, K. M., Castro, M., Qin, Y., Rupani, H., Sagara, H., Howarth, P. H., & Taillé, C. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.06.005 · Cited by 120
Self-citationChronic rhinosinusitis: Endotypes, biomarkers, and treatment response
Gurrola, J. G., & Borish, L. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.006 · Cited by 119
Hoggard, M., Mackenzie, B. W., Jain, R., Taylor, M. W., Biswas, K., & Douglas, R. G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-16 · Cited by 122
GEMA 5.3. Spanish Guideline on the Management of Asthma
Plaza, V., Alobid, I., Rodríguez, C. Á., Blanco‐Aparicio, M., Ferreira, J., García, G., Gómez‐Outes, A., Garín, N., Ruiz, F. G., Requena, A. H., et al. (2023) · Open Respiratory Archives · doi:10.1016/j.opresp.2023.100277 · Cited by 121
Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size
Laidlaw, T. M., Prussin, C., Panettieri, R. A., Lee, S. J., Ferguson, B. J., Adappa, N. D., Lane, A. P., Palumbo, M. L., Sullivan, M. E., Archibald, D., et al. (2018) · The Laryngoscope · doi:10.1002/lary.27564 · Cited by 116
Pathogenesis of eosinophilic chronic rhinosinusitis
Shah, S. A., Ishinaga, H., & Takeuchi, K. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0121-8 · Cited by 115
Bachert, C., Hicks, A., Gane, S. B., Peters, A. T., Gevaert, P., Nash, S., Horowitz, J. E., Sacks, H. J., & Jacob-Nara, J. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1356298 · Cited by 129
Self-citationComplex phenotypes in asthma: Current definitions
Wenzel, S. E. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.07.003 · Cited by 117
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which
Maurer, M., Khan, D. A., Komi, D. E. A., & Kaplan, A. P. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.11.043 · Cited by 112
Biologics in chronic rhinosinusitis with nasal polyposis
Laidlaw, T. M., & Buchheit, K. M. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.12.001 · Cited by 111
A Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes
Dennis, S. K., Lam, K. K., & Luong, A. (2016) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.32 · Cited by 109
Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine
Kim, D. W., & Cho, S. (2017) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2017.9.4.299 · Cited by 109
Leopold, D. A., Elkayam, D., Messina, J. C., Kosik‐Gonzalez, C., Djupesland, P. G., & Mahmoud, R. A. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.06.010 · Cited by 109
Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps
Bachert, C., Gevaert, P., & Hellings, P. W. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.04.024 · Cited by 106
Self-citationEAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
Boyman, O., Kaegi, C., Akdiş, M., Bavbek, S., Bossios, A., Chatzipetrou, A., Eiwegger, T., Firinu, D., Harr, T., Knol, E. F., et al. (2015) · Allergy · doi:10.1111/all.12616 · Cited by 105
Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs
Laidlaw, T. M., & Cahill, K. N. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.10.021 · Cited by 105
Late-onset asthma: current perspectives
Hirano, T., & Matsunaga, K. (2018) · Journal of Asthma and Allergy · doi:10.2147/jaa.s125948 · Cited by 105
Frøssing, L., Silberbrandt, A. W., von Bülow, A., Backer, V., & Porsbjerg, C. M. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.09.051 · Cited by 106
Bachert, C., Hellings, P. W., Mullol, J., Hamilos, D. L., Gevaert, P., Naclerio, R. M., Joish, V. N., Chao, J., Mannent, L., Amin, N., et al. (2019) · Allergy · doi:10.1111/all.13984 · Cited by 102
Self-citationIL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease
Buchheit, K. M., Dwyer, D. F., Ordovás-Montañés, J., Katz, H. R., Lewis, E., Vukovic, M., Lai, J., Bankova, L. G., Bhattacharyya, N., Shalek, A. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.02.035 · Cited by 101
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps
Peters, A. T., Han, J. K., Hellings, P. W., Heffler, E. M., Gevaert, P., Bachert, C., Xu, Y., Chuang, C., Neupane, B., Msihid, J., et al. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.01.031 · Cited by 104
Self-citationBiologics for chronic rhinosinusitis
Chong, L., Piromchai, P., Sharp, S., Snidvongs, K., Webster, K. E., Philpott, C. M., Hopkins, C. L., & Burton, M. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013513.pub3 · Cited by 105
Thirty years of endoscopic sinus surgery: What have we learned?
Tajudeen, B. A., & Kennedy, D. W. (2017) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1016/j.wjorl.2016.12.001 · Cited by 100
NSAID-induced reactions: classification, prevalence, impact, and management strategies
Blanca‐López, N., Soriano-Gomis, V., García‐Martín, E., Cantó, G., & Blanca, M. (2019) · Journal of Asthma and Allergy · doi:10.2147/jaa.s164806 · Cited by 100
Endotypes of chronic rhinosinusitis: Impact on management
Cardell, L., Stjärne, P., Jonstam, K., & Bachert, C. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.019 · Cited by 99
Self-citationInflammation and Endotyping in Chronic Rhinosinusitis—A Paradigm Shift
Ahern, S., & Cervin, A. (2019) · Medicina · doi:10.3390/medicina55040095 · Cited by 101
Weinstein, S. F., Katial, R. K., Bardin, P. G., Korn, S., McDonald, M., Garin, M. C., Bateman, E. D., Hoyte, F. C. L., & Germinaro, M. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.08.021 · Cited by 92
Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease
Buchheit, K. M., Lewis, E., Gakpo, D. H., Hacker, J. J., Sohail, A., Taliaferro, F., Giron, E. B., Asare, C., Vukovic, M., Bensko, J. C., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.05.043 · Cited by 92
Tversky, J. R., Lane, A. P., & Azar, A. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.13852 · Cited by 90
Liu, Z., Chen, J., Cheng, L., Li, H., Liu, S., Lou, H., Shi, J., Ying, S., Wang, D., Wang, C., et al. (2020) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2020.12.2.176 · Cited by 89
Sindwani, R. H., Han, J. K., Soteres, D. F., Messina, J. C., Carothers, J. L., Mahmoud, R. A., & Djupesland, P. G. (2018) · American Journal of Rhinology and Allergy · doi:10.1177/1945892418810281 · Cited by 87
Clinical reviews in allergy and immunology
Leung, D. Y. M., Ledford, D. K., Wechsler, M. E., Fulkerson, P. C., Bochner, B. S., Gauvreau, G. M., Gleich, G. J., Henkel, T., Kolbeck, R., Mathur, S. K., et al. (2012) · Cited by 87
Kern, R. C., Stolovitzky, J. P., Silvers, S. L., Singh, A., Lee, J. T., Yen, D. M., Iloreta, A. M., Langford, F. P. J., Karanfilov, B. I., Matheny, K. E., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22084 · Cited by 86
Gevaert, P., Craemer, J. D., Bachert, C., Blauwblomme, M., Chaker, A. M., Cingi, C., Hellings, P. W., Hopkins, C. L., Hox, V., Fokkens, W. J., et al. (2023) · Allergy · doi:10.1111/all.15650 · Cited by 84
Self-citationCorso, E. D., Bellocchi, G., Benedetto, M. D., Lombardo, N., Macchi, A., Malvezzi, L., Motta, G., Pagella, F., Vicini, C., & Passali, D. (2021) · Acta Otorhinolaryngologica Italica · doi:10.14639/0392-100x-n1614 · Cited by 81
Immunological and hematological effects of IL ‐5(Rα)‐targeted therapy: An overview
Hassani, M., & Koenderman, L. (2018) · Allergy · doi:10.1111/all.13451 · Cited by 82
Chusid, M. J. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.04.031 · Cited by 81
Current and Future Treatments of Rhinitis and Sinusitis
Patel, G. B., Kern, R. C., Bernstein, J. A., Hae-Sim, P., & Peters, A. T. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.01.031 · Cited by 81
Pathogenesis and Management of Nasal Polyposis in Cystic Fibrosis
Mainz, J. G., & Koitschev, A. (2012) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0250-y · Cited by 81
Metadata
- Authors
- Gevaert, P., Van Bruaene, N., Cattaert, T., Van Steen, K., Van Zele, T., Acke, F., De Ruyck, N., Blomme, K., Sousa, A. R., Marshall, R. P., & Bachert, C.
- Affiliations
- Ghent University (BE)
- University of Liège (BE)
- GlaxoSmithKline (United Kingdom) (GB)
- Corresponding author
- Gevaert, Philippe
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 128
- Issue
- 5
- Pages
- 989-995.e8
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W1968876836
- Cited by
- 629
- References
- 31
- Citations by year
- 2026: 21 · 2025: 26 · 2024: 31 · 2023: 45 · 2022: 29 · 2021: 73 · 2020: 80 · 2019: 56 · 2018: 64 · 2017: 55 · 2016: 52 · 2015: 36 · 2014: 15 · 2013: 16 · 2012: 27
- FWCI
- 17.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Allergy and Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Lirias (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- Funders
- GlaxoSmithKline
- Fonds De La Recherche Scientifique - FNRS
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering
- Topics
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- mepolizumab, IL-5 inhibition, nasal polyps, eosinophilic rhinosinusitis, humanized monoclonal antibody, corticosteroid-refractory disease, eosinophilia, anti-IL-5 therapy
- MeSH terms
- Double-Blind Method, Eosinophilia, Female, Humans, Male, Middle Aged, Nasal Polyps, Interleukin-5, Eosinophil Cationic Protein, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
